Four years after Omeros came up short in its bid to gain an FDA approval for stem cell transplant drug narsoplimab, the ...
Seattle, USA-based biotech Omeros Corp saw its shares leap 75.5% to $15.36 by close of trading Wednesday, as it revealed that ...
The biopharmaceutical company announced BHV-7000, an investigational drug for major depressive disorder, failed to achieve a reduction in depressive symptoms versus placebo in the six-week study, ...
Multi Ways Holdings Ltd (NYSE: MWG) shares jumped 22.2% to $0.43 in pre-market trading. Multi Ways Holdings shares gained over 38% on Wednesday after the company reported a year-over-year increase in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback